Click Here To Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/4540

A bone densitometer is used to precisely measure the density and mineral content present in the bones to diagnose clinical conditions such as osteoporosis that may cause brittle bones prone to fracture.
High incidence of disorders that cause loss of bone density, rapid increase of geriatric population, increase in technological advancements, and benefits offered by DEXA device drive the market growth. However, high cost of bone densitometers and risks associated with them limit the market growth. Conversely, launch of several health initiatives to promote awareness about osteoporosis is expected to present opportunities for market growth during the forecast period.

On the basis of technology, DEXA is expected to maintain its dominant position during the analysis period, owing to its high precision, easy handling, and safety for both adults & children use.
Based on application, the central scan segment held the major market share (more than half) in 2016, and is expected to dominate the market throughout the forecast period, owing to its effectiveness to predict fracture risk, effective targeting of antifracture treatments, high accuracy, availability of reliable reference ranges, rapid patient setup, short scan times, and low radiation dose.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/4540

Key Findings of the Bone Densitometers Market:

·         The peripheral scan segment is expected to grow with a CAGR of 3.8% from 2017 to 2023.

·         Ultrasound segment is expected to grow at the highest CAGR of 4.3%.

·         The hospitals segment held a major share of nearly two-thirds in the global market, and is expected to retain it throughout the forecast period.

·         Asia-Pacific is expected to grow at a CAGR of 5.3% during the forecast period.

Europe accounted for a major share of nearly two-fifths of the global market in 2016, and is expected to remain dominant throughout the forecast period. This is attributed to increase in incidence of osteoporosis, increase in geriatric population, rise in patient awareness about the availability of treatment options, and favorable reimbursement framework for bone densitometry in the region.

know more: https://www.openpr.com/news/2165982/bone-densitometers-market-expected-to-reach-44-218-thousand

Gene therapies are promising therapies applicable to a broad range of diseases; their aim is to radically treat the causes of the diseases instead of only relieving the symptoms. They may be effective on a wide range of previously untreated diseases, such as hematological, ocular, neurodegenerative diseases, and several cancers. For example, adeno associated AAV2 vectors carrying the therapeutic gene (RPE65) intra-retinal injection resulted in improved vision for people with Leber’s Congenital Amaurosis. Gene therapies can be applied either in combination with cell products and through an ex vivo treatment mode (e.g. Strimvelis), or directly administered in vitro (e.g. Glybera). Several vectors present clinically relevant options, including adenovirus (AV), adeno-associated virus (AAV), and lentivirus.

Click Here To Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/2841

The increase in funding for R&D activities pertaining to gene therapy and increase in awareness regarding gene therapy are the major factors that drive the gene therapy market growth. In addition, increase in government support, ethical acceptance of gene therapy for cancer treatment, and rise in prevalence of cancer can fuel the growth of the gene therapy market. However, high cost associated with the treatment and unwanted immune responses are expected to hamper the growth of the gene therapy market.

Among the vector type, non-viral vector is anticipated to be a lucrative in the global gene therapy market, due to the technological advancements such as physicochemical approaches that includes material such as lipid, naked DNA, chromosomes, plasmid, cationic polymers, and conjugate complexes of these vectors with positive results for these therapies during the preclinical and clinical trials for the treatment of various diseases.

Among the gene type, antigen dominates the overall market accounting for two-ninths of the global gene therapy market share in 2018. Among the applications, oncological disorders segment is the largest contributor towards the growth of the gene therapy market, owing to due to the availability of many gene therapy products that can be used to treat cancer and large patient population base. In addition, there are large number of gene therapies undergoing clinical trials for cancer and cardiovascular diseases.

In 2018, North America accounted for maximum contribution to the total revenue generated, and is anticipated to continue this gene therapy market trends during the forecast period. This is attributed to the high prevalence rate of cancer, presence of high disposable income, and high funding for R&D activities associated with gene therapy. However, Asia-Pacific is expected to witness the highest CAGR during the forecast period owing to rise in incidence rate of cancer, increase in government initiative to improve healthcare infrastructure, and rise in healthcare expenditure.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/2841

Key Findings of the Gene Therapy Market :

Non-viral vectors segment is projected to grow at the highest rate with the CAGR of 34.6% during the analysis period.

Oncological disorders segment generated the highest revenue, and is expected to continue its dominance in future in the global gene therapy market.

Asia-Pacific is projected to grow at the fasted CAGR during the forecast period.

China is expected to grow highest in the Asia-Pacific region during the forecast period.

Tumor suppressor is the expected to grow fastest during the forecast period.

The report provides a comprehensive analysis of the key players operating in the global gene therapy market industry, namely Adaptimmune Therapeutics Plc., Anchiano Therapeutics Ltd., Achieve Life Sciences, Inc., Adverum Biotechnologies, Inc., Abeona Therapeutics Inc., Applied Genetic Technologies Corporation, Arbutus Biopharma Corporation, Audentes Therapeutics, Inc., AveXis, Inc., Bluebird Bio, Inc., Celgene Corporation, CRISPR Therapeutics AG, Editas Medicine, Inc., Editas Medicine, Inc., GlaxoSmithKline Plc., Intellia Therapeutics, Inc., Merck & Co., Inc., Novartis AG, REGENXBIO Inc., Spark Therapeutics, Inc., Sangamo Therapeutics, Inc., Uniqure N. V., Voyager Therapeutics, Inc.

Other prominent players in the value chain (companies not profiled in the report) includes Amgen, Epeius Biotechnologies, Sanofi, Juno Therapeutics, and Advantagene.

know more: https://www.openpr.com/news/2165975/gene-therapy-market-2020-analysis-with-covid-19-effects

Disposable gloves form an essential part in maintaining hygienic conditions, ensuring security of patients and caregivers, and safeguarding against infections. These are used while performing laboratory experiments to ensure safety of personnel. The use of gloves minimizes possibility of infection, pathogens, and other external factors. Adoption of disposable gloves has been a prerequisite for medical applications across the world. Advent of newer manufacturing technologies, increase in awareness regarding benefits of disposable gloves and improved healthcare practices are expected to catalyze the market growth.

Request for Free Sample Report at: https://www.alliedmarketresearch.com/request-sample/274

Medical gloves are essential during the COVID-19 outbreak. They help slow the spread of the disease by protecting hands from coarse contaminants and protect health care providers. Medical gloves is a form part of the personal protective equipment (PPE) that are used to protect health care professionals and patients from spread of infection. In addition, in May 2020, CDC recommended that the use of gloves should be during food handling, cleaning, gardening, trades, or caring for someone who is sick, and while in contact with blood, stool, or body fluids, such as saliva, mucus, vomit, and urine.

The market for disposable gloves is primarily driven by their requirement in medical and surgical applications to ensure safety and hygiene. In addition, growth in number of end users, such as healthcare, pharma, and food industries, is expected to supplement the market growth. However, toxic reaction from certain gloves as well as competition pricing offered by local manufacturers hamper the market growth. Moreover, advancements in technology related to development of novel disposable gloves are expected to create lucrative opportunities for the market players in the future.

The demand for disposable gloves is expected to rise in the future, owing to necessity for product quality control, workers safety, hygiene, and protection. Healthcare professional, doctors, and surgeons use medical gloves during surgeries and other activities to prevent infection and cross contamination. Furthermore, disposable gloves have applications in household purposes for cleaning and dish washing. Thus, the market for disposable gloves is expected to grow in the near future, owing to rise in concern for safety, hygiene, and product quality.

By type, the nitrile gloves segment was the highest contributor to the global disposable gloves market revenue as these are widely used in healthcare settings for protection against disinfectants and other related harmful chemical agents.

By form, the powder form segment is expected to dominate the global disposable gloves market during the forecast year as these gloves are convenient to use, owing to their non-sticky nature and facilitates easy removal after use. In addition, powdered disposable gloves tweak the surface weakness property of natural rubber latex, making them easy to put on.

In 2019, Europe was the dominant revenue contributor, owing to increase in awareness about hygiene, growth threat of infection & contamination among the end users, and improvised safety regulations. However, Asia-Pacific is expected to witness the highest CAGR during the forecast period, owing to presence of high populace in countries such as India and China, which have a prominent prevalence rate of chronic diseases, geriatric population, and unmet medical needs.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/274

Emerging countries are expected to provide lucrative opportunities for disposable gloves manufacturers, owing to rise in disposable income, increase in awareness regarding disposable gloves, and growth in healthcare expenditure. Spur in the medical tourism industry is a key driver of the disposable gloves market in emerging economies such as India, South Korea and other. In emerging economies, healthcare scenario has improved at a steady rate, owing to growth in awareness regarding healthcare and proactive government initiatives.

Key Findings Of The Study 

·         The study provides an in-depth analysis, current trends, and future estimations of the global disposable gloves market to elucidate the imminent investment pockets.

·         Comprehensive analysis of factors that drive and restrict the disposable gloves market growth is provided.

·         By type, the nitrile gloves segment is anticipated to grow at a CAGR of 14.2% from 2020 to 2027.

·         Extensive analysis of key segments of the industry help to understand the types of products and application used across various geographies.

know more: https://www.openpr.com/news/2165966/disposable-gloves-market-expected-to-enable-the-stakeholders

Digital pathology (DP) is an emerging technology in the field of pathology, where test results are converted into digital images for easy viewing, analysis, storage, and management of the collected data. This is expected to result in many advancements and upgradation of conventional pathology. Thus, lack in number of pathologists globally is addressed by the use of digital pathology, which is the major benefit of this technology. In addition, increase in applications of digital pathology for disease consultation, especially for cancer, boosts the market growth. The other key factors contributing to the growth of this market are rise in prevalence of chronic diseases and ease in virtual transportation of slides. However, lack of reimbursement policies, inadequate infrastructure, and high cost of digital pathology devices restrict the growth of the market.

Click Here To Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/74

Based on product type, the scanners segment is expected to register significant growth rate during the forecast period, owing to the benefits offered by digital pathology scanners such as it aids in analyzing multitude of images with ease and in studying complex morphologies & features. In addition, these systems perform repeated data analysis across experiments and produce images with high resolution. Moreover, the recent approvals granted by FDA boost the growth of digital pathology scanners market.

Based on application, the drug discovery segment will show significant market growth, owing to growth in number of research activities and increase in adoption of digital scanning among the pharmaceutical and biopharmaceutical companies.

Among end users, the pharma & biotech companies segment accounted for the largest share in the global digital pathology market, as it delivers well-organized, documented, retrieved, and logistical pathological procedures. However, clinical segment will show fastest market growth due to rise in number of clinics incorporating digital pathology over traditional pathology, which in turn fuels the digital pathology market growth.

Asia-Pacific is expected to witness highest growth rate in the global market, and is expected to continue this trend throughout the forecast period. This is attributed to high population density and rise in incidence of chronic diseases across high populous countries such as India and China. Moreover, growth in adoption of digital pathology will further boost the market growth.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/74

Key Findings of the Digital Pathology Market: 

• Scanners segment occupied more than half share of the global digital pathology market in 2018.
• The clinical segment is anticipated to grow with the highest CAGR throughout the forecast period.
• The disease diagnosis segment accounted nearly one third share of the market in 2018.
• Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.

know more: https://www.openpr.com/news/2165958/digital-pathology-market-which-like-to-develop-revenue-growth

Gynecology is the main branch of medical science concerned with women's health problems. This includes the health related disorders, their screening and testing procedures. Women are highly prone to various cancers such as breast, cervical, and ovarian cancer. Other health issues include infertility, polycystic ovarian syndrome, menopause, depression, osteoporosis, and obesity.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/4521

Factors such as rise in prevalence of various chronic lifestyle disorders in women, rise in female geriatric population who are more prone to several disorders, increase in adoption of point of care diagnosis, high demand for imaging and diagnosing centers, and support from government in promoting awareness about women related disorders. However, factors such as expensive imaging procedures and lack of skilled professionals restrains the market growth. Conversely, huge untapped market potential in the emerging countries, such as South Africa and India, and development of novel and advanced imaging procedures such as miniature devices are expected to provide lucrative opportunities to the market players.

The diagnostic tests segment occupied the largest share in 2016, owing to the high usage, applicability, and availability of tests for detecting various disorders in women. Furthermore, the accessories and consumables segment is expected to grow at the highest CAGR of 7.8% from 2017 to 2023, and is anticipated to continue its dominance during the forecast period. The utilization rate of various women's health related diagnostics procedures for hospitals and clinics is high, however diagnostic and imaging centers segment is expected to grow at a CAGR of 7.8% during the forecast period. This is attributed to increase in incidence of various types of health-related disorders.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/4521

Key findings of the Women's Health Diagnostics Market:

• Diagnostic tests segment accounted for around 55.1% share of the global women's health diagnostics market in 2016
• Diagnostic devices segment is expected to grow at a CAGR of 6.5% from 2017 to 2023.
• Hospitals and clinics segment accounted for around 49.8% share of the global women's health diagnostics market in 2016
• North America accounted for around 33.7% share of the global women's health diagnostics market in 2016
• Asia-Pacific is expected to grow at the highest CAGR of 8.1% from 2017 to 2023

North America was the leading revenue contributor to the global women's health diagnostics market, accounting for nearly one-third of the global market. This is attributed to the presence of numerous screening tests for cancer detection and other diseases. Moreover, presence of key players and advanced diagnostics procedures such as 3D mammography. However, Asia-Pacific is expected to grow at the highest CAGR of 8.1% during the study period, due to increase in affordability, surge in healthcare expenditure, and rise in awareness towards various women related disorders.

know more: https://www.openpr.com/news/2165944/womens-health-diagnostics-market-analysis-with-covid-19

Insomnia is a sleep disorder where in people have problem in falling asleep or remaining asleep. The major causes of insomnia include high stress level, mental disorders, excessive consumptions of caffeine & alcohol, and other medical conditions. Insomnia is categorized into three types depending on the duration of the disorder, namely transient (few days), acute (few weeks), and chronic insomnia (few months or even years).

Click Here To Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/2373

The global insomnia market is driven by factors such as emergence of therapeutics with fewer side-effects and rise in demand for over-the-counter (OTC) sleep aids. Few drugs that are used for the treatment of chronic diseases affect the quality of sleep; thereby, increasing the number of insomnia cases. Furthermore, rise in geriatric population and growth in disposable income are expected to boost the market growth. However, the side-effects caused due to excessive use of sleep medication and patent expiration of many prescription drugs are expected to hamper the market growth.

The pharmacological therapy segment is the highest contributor to the market growth. The non-pharmacological therapy segment is anticipated to be lucrative for market players, as these therapies cause fewer side effects as compared to drugs.

In 2016, North America accounted for the maximum contribution to the total revenue generated, owing to the high prevalence rate of insomnia, presence of high disposable income, and high demand for over-the-counter (OTC) drugs. In addition, the presence of large number of insomnia centers in this region and rise in the number of patients with chronic renal & kidney diseases are expected to boost the market growth. However, Asia-Pacific is expected to witness the highest CAGR during the study period, owing to increase in the number of people working at odd hours, rise in incidence rate of insomnia, and growth in disposable income.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/2373

Key Findings of the Insomnia Market:

• The cognitive behavioral therapy segment is anticipated to grow at the highest rate during the analysis period.
• The prescription drugs segment generated the highest revenue, and is expected to continue its dominance in the near future.
• North America dominated the global insomnia market, and is anticipated to continue its dominance in the future.
• China is expected to grow at highest CAGR in the Asia-Pacific.
• The pharmacological therapy segment was the largest contributor to the market growth, in 2016.

The key companies profiled in the report include Merck & Co. Inc., Sanofi India Limited, Pfizer, Inc., Takeda Pharmaceutical Company Ltd., Purdue Pharmaceuticals L.P., Eisai, Co. Ltd., Meda Consumer Healthcare Inc., Pernix Therapeutics, Vanda Pharmaceuticals, and ECR Pharmaceuticals.

Precision medicine is novel approach toward disease treatment in healthcare, medications are customized based on patients personalized healthcare needs such as, influence of genes & surrounding environment on patients health and result of various tests carried out on various levels. Follow-up on tests and treatment can be planned based on response of the patients toward treatment, which reduces side effects of drug and multiple administration of medications.

Click Here To Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/2311

The precision medicine market is expected to grow at a productive rate the during forecast period. Surge in global incidence of cancer and increase in aging population susceptible to diseases are expected to boost the demand of precision medicines. Government initiatives & grants and private companies investing in R&D of precision medicines boost the market growth. However, strict regulation set by governments and risk associated with sharing genetic data of patients impedes the growth of precision medicine market.

Drug discovery generated the highest revenue in 2016, and is anticipated to continue this trend in the future. The requirement of quality drugs and versatile therapies for treatment is expected to boost the growth of this segment. Gene sequencing grows at a surprising rate and is expected to continue to grow during the forecast period.

North America holds the highest market share in 2016 owing to high prevalence rate of cancer and modern healthcare facilities. Moreover, adoption of experimental medicines and growth in awareness about precision medicines is expected to boost the North America market. However, Asia-pacific region is expected to grow at the highest CAGR during the forecast period considering, swift industrialization in the area, increase in disposable income, and upsurge in government initiatives to modernize healthcare infrastructure.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/2311

Key Findings of the Precision Medicine Market:

• The sequencing by synthesis segment is projected to grow at the highest CAGR during the analysis period.
• Consumables segment generated the highest revenue and is expected to continue its dominance in future.
• North America dominated the market and is projected to grow at a CAGR of 11.0%.
• China is expected to grow at the highest CAGR of 16.8% in Asia-Pacific.
• The epigenomics segment is anticipated to grow at the highest CAGR of 14.1% during the forecast period.

The key companies profiled in the report include Roche Holding AG, Illumina Inc., Thermo Fisher Scientific Inc., QIAGEN, Quest Diagnostics, Laboratory Corporation of America Holdings, Novartis AG, AstraZeneca, Bristol-Myers Squibb, and Eli Lilly & Company.

Medical cart/trolley is a mobile equipment, which consists of a set of shelves, trays, compartments, and drawers for hospital use and medical settings. It carries, dispense, and transport emergency drugs, medicines, medical devices, and medical instruments. Carts are a crucial aspect of medical aid as it provides storing, recording, and dispensing drugs, supplies, and patient information along with patient care. Many carts are designed to supply various surgical and emergency needs depending on the operating room and other medical settings.

Click Here To Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/2284

The emergency carts segment is expected to dominate the Asia-Pacific medical carts market throughout the forecast period, both in terms of value and volume. China dominated the Asia-Pacific medical carts market in 2016, accounting for more than one-third market share in terms of value, and is projected to continue this trend in the future. In addition, growth in improvement of patient safety and nursing efficiency supplement the market growth. Further, advancement in technologies, such as telemedicine offer lucrative opportunities for the growth of this market. However, lack of skilled professionals, high cost of medical carts, and limited government funding restrain the market growth.

The emergency carts segment is anticipated to maintain its dominance, generating highest revenue throughout the forecast period, owing to the large-scale employment of emergency carts at the time of crisis. This is because emergency carts contain sophisticated devices, such as defibrillators, suction devices, advanced cardiac life support (ACLS), apart from drugs, such as atropine, dopamine and others. In addition, it also includes generic drugs to treat common problems, rapid sequence intubation, and pediatric equipment. However, procedure carts segment is growing at the highest CAGR of 13.0% from 2017 to 2023 in terms of value, as it consists many medical equipment that aid in operating procedures, such as endoscopy, cardiology and others and provides access to essential drugs at the same time.

Key Findings of the Medical Carts Market:

• The procedure carts segment is anticipated to grow at the highest growth rate during the forecast period.
• North America dominated the global medical carts market, accounting for maximum share of overall market in 2016.
• Asia-Pacific is exhibited to grow at a higher growth rate of 13.5% during the forecast period in terms of value, owing to the high population base in countries, such as India and China.
• The emergency cart segment dominated the overall market in 2016, growing at a CAGR of 12.3% in terms of value, from 2017 to 2023.
• In terms of both value and volume, China accounted for the largest share in 2016, and is anticipated to maintain this trend throughout the forecast period in Asia-Pacific region.
• UK is expected to grow at a remarkable CAGR of 13.8% in terms of value and 13.2% in terms of volume during the forecast period.
• In terms of volume, procedure carts are anticipated to grow at the highest rate of 12.9% from 2017 to 2023.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/2284

Asia-Pacific has witnessed highest growth rate for medical carts during the forecast period, and is expected to continue this trend. This is attributed to increase in sizeable population, rise in incidence of diseases and injuries, healthcare infrastructural development, and huge market potential, owing to the arrival of new and robust carts by key players focusing on the emerging markets.

Key players operating in the medical carts market have adopted product launch as their key developmental strategy, and focus on launching innovative products to cater to the consumer requirements and strengthen their market share. The major companies profiled in the report include InterMetro Industries Corporation (A Part of Ali Group), Harloff Company (Harloff Manufacturing Co.), Armstrong Medical, Capsa Solutions LLC., Omnicell Inc., Medline Industries Inc., ITD GmbH, Midmark Corporation, The Bergmann Group, and Life-Medic HealthCare Supplies Pte Ltd.

The other key players in the value chain include Jegna, Herman Miller, Inc., Zhangjiagang Bestran Technology Co. Ltd., Merino International, BiHealthcare, Tianjin Xuhua Medical Equipment Factory, Medical Master, Hua Shuo Plastic Co., Ltd., Joson-Care Enterprise Co., Ltd., and Tonglu Rex Medical Instrument Co., Ltd.

Click Here To Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/2278

Neurovascular devices are used for the treatment of neurovascular disorders such as cerebral aneurysm. Increase in geriatric population and rise in number of patients suffering from neurovascular disorders are expected to drive the market growth. Moreover, surge in adoption of new minimally invasive devices such as flow diversion and carotid artery stents boosts the market growth. However, high cost of the devices and dearth of neurosurgeons are expected to impede the market growth.

Embolization devices segment is expected to dominate the market throughout the analysis period, owing to increase in the incidence of neurovascular disorders, such as arteriovenous malformations (AVMs), carotid artery disease, and intracranial atherosclerotic disease. On the other hand, revascularization devices segment is expected to grow at the highest CAGR of 8.5% during the forecast period.

Key Findings of the Neurovascular Devices Market:

• Revascularization devices segment is projected to grow at a CAGR of 8.5% during the forecast period.
• Aneurysm contributed for nearly three-fifths share of the global neurovascular devices market in 2016.
• Ischemic stroke segment is expected to register the highest CAGR of 5.7% during the analysis period.
• France and Germany jointly contributed for more than one-third share of the European neurovascular devices market in 2016.
• Japan is the major shareholder, accounting for more than one-third share of the Asia-Pacific neurovascular devices market in 2016.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/2278

Asia-Pacific is projected to grow at the highest CAGR of 5.9% during the forecast period owing to improvement in healthcare infrastructures and rise in expenditures in emerging markets (such as India and China) to cater to the unmet medical needs. Technological advancements to develop cost-effective devices in these nations offer a lucrative opportunity for the market growth.

The major companies profiled in the report include Stryker Corporation, Medtronic Plc., Johnson & Johnson, Terumo Corporation, Penumbra, Inc., Integer Holdings Corporation, Microport Scientific Corporation, Merit Medical Systems, Inc., W.L. Gore & Associates, and Acandis GmbH & Co. KG.

Click Here To Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/2274

Cone beam computed tomography (CBCT) systems are a special type of x-ray equipment. These systems are used by medical professionals to reconstruct a 3D image of various regions of patients anatomy such as dental, oral and maxillofacial region, and ears, nose and throat.

Rise in geriatric population, wide range of applications of CBCT systems in dental practice and upsurge in number of patients suffering from dental diseases are expected to drive the market growth. Moreover, expanding application of CBCT systems in other medical fields such as breast imaging further boosts the market growth. However, high cost of the devices and image related issues such as lack of clarity are expected to impede the market growth.

Dental application segment is expected to dominate the market throughout the analysis period, owing to the increase in the incidence of dental disorders, such as tooth loss, periodontal disorders, and TMJ disorders. On the other hand, other application segment is expected to grow at the highest CAGR of 11.8% during the forecast period.

Key Findings of the CBCT Systems Market:

• Breast imaging segment is projected to grow at a CAGR of 12.2% during the forecast period.
• Hospitals & Clinics accounted for more than three-fifths share of the global CBCT systems market in 2015.
• Flat-panel image detector is expected to register the highest CAGR of 10.0% during the analysis period.
• France and Germany jointly contributed for more than one-third of the European CBCT systems market in 2016.
• Japan is the major shareholder, accounting for more than one-third of the Asia-Pacific CBCT systems market in 2015.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/2274

Asia-Pacific is projected to grow at the highest CAGR of 10.1% during the forecast period owing to improvement in healthcare infrastructures and rise in expenditures in emerging markets (such as India and China) to overcome the unmet medical needs. Technological advancements to develop cost-effective devices in these nations offer a lucrative opportunity for market growth.

The major companies profiled in the report include Carestream Health, Danaher, Planmeca OY, Dentsply Sirona, Vatech Co., Ltd., Cefla s.c., ASAHIROENTGEN IND.CO., LTD., J. Morita, Curve Beam, and Prexion.